09:32 EST Bluebird Bio (BLUE) trading halted, volatility trading pause
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLUE:
- Bluebird Bio downgraded to Neutral from Outperform at Baird
- Morning Movers: Bluebird Bio shares tumble following take-private deal
- Bluebird Bio to be acquired by Carlyle, SK Capital for $3.00 per share
- Bluebird Bio Ends Sublease Agreement with Meta and Aventis
- Bluebird Bio price target lowered to $8 at RBC Capital on ‘limited cash runway’